Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « them »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
thanks < them < theme  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]
Ident.Authors (with country if any)Title
000049 (2012) Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000053 (2011) Ryota Sakai [Japon] ; Hayato Nagasawa [Japon] ; Eiko Nishi [Japon] ; Ayumi Okuyama [Japon] ; Hirofumi Takei [Japon] ; Takahiko Kurasawa [Japon] ; Tsuneo Kondo [Japon] ; Koji Nishimura [Japon] ; Yuichiro Shirai [Japon] ; Tatsuya Ito [Japon] ; Hideto Kameda [Japon] ; Tsutomu Takeuchi [Japon] ; Koichi Amano [Japon]Successful treatment of adult-onset Still’s disease with tocilizumab monotherapy: two case reports and literature review
000085 (2011) Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
000160 (2011) Susumu Nishiyama [Japon] ; Tetsushi Aita [Japon] ; Yasuhiko Yoshinaga [Japon] ; Hiroki Kishimoto [Japon] ; Michio Toda [Japon] ; Yoshiki Yoshihara [Japon] ; Shinya Miyoshi [Japon] ; Akira Manki [Japon] ; Shoji Miyawaki [Japon]Proposing a method of regional assessment and a novel outcome measure in rheumatoid arthritis
000536 (2009) Katalin Eder [Hongrie] ; Noemi Baffy [Hongrie] ; Andras Falus [Hongrie] ; Andras K. Fulop [Hongrie]The major inflammatory mediator interleukin-6 and obesity
000803 (2012) Sharon Cohen [Israël] ; Ilan Bruchim [Israël] ; Dror Graiver [Israël] ; Zoharia Evron [Israël] ; Varda Oron-Karni [Israël] ; Metsada Pasmanik-Chor [Israël] ; Ram Eitan [Israël] ; Joelle Bernheim [Israël] ; Hanoch Levavi [Israël] ; Ami Fishman [Israël] ; Eliezer Flescher [Israël]Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
000875 (2012) Nicolino Ruperto [Italie] ; Pierre Quartier [France] ; Nico Wulffraat [Pays-Bas] ; Patricia Woo [Royaume-Uni] ; Angelo Ravelli [Italie] ; Richard Mouy [France] ; Brigitte Bader-Meunier [France] ; Sebastiaan J. Vastert [Pays-Bas] ; Emanuele Noseda [Suisse] ; Daniele D'Ambrosio [Suisse] ; Jean Lecot [Suisse] ; Abhijit Chakraborty [Suisse] ; Alberto Martini [Italie] ; Andrea Chioato [Suisse]A phase II, multicenter, open‐label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
000A54 (2011) Homam Alkaied [États-Unis] ; Kassem Harris [États-Unis] ; Dany Elsayegh [États-Unis] ; Inga Khachaturova [États-Unis] ; Michael Awasum [États-Unis] ; Seema Varma [États-Unis]Does Kaposi’s sarcoma predict multicentric Castleman disease in the presence of generalized lymphadenopathy?
000A57 (2011) Mara Anaís Llamas-Covarrubias [Mexique] ; Yeminia Valle [Mexique] ; Rosa Elena Navarro-Hernández [Mexique] ; Iris Paola Guzmán-Guzmán [Mexique] ; María Guadalupe Ramírez-Due As [Mexique] ; Héctor Rangel-Villalobos [Mexique] ; Ciro Estrada-Chávez [Mexique] ; José Francisco Mu Oz-Valle [Mexique]Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course
000A67 (2011) W. Hermann [Allemagne]Reisen bei rheumatischen Erkrankungen
000A69 (2011) Babasaheb Bandgar [Inde] ; Baliram Hote [Inde] ; Rahul Gangwal [Inde] ; Abhay Sangamwar [Inde]Synthesis, biological evaluation, and pharmacokinetic profiling of benzophenone derivatives as tumor necrosis factor-alpha and interleukin-6 inhibitors
000A78 (2012) Yayoi Nagai [Japon] ; Michiko Hasegawa [Japon] ; Etsuko Okada [Japon] ; Tomoyasu Hattori [Japon] ; Osamu Tago [Japon] ; Osamu Ishikawa [Japon]Clinical follow‐up study of adult‐onset Still’s disease
000B27 (2012) Jae Kuk Ryu [Corée du Sud] ; Hyo Sun Kim [Corée du Sud] ; Doo Hyun Nam [Corée du Sud]Current status and perspectives of biopharmaceutical drugs
000C76 (2011) P. Willeke [Allemagne] ; H. Becker [Allemagne] ; S. Wassenberg [Allemagne] ; H. Pavenst Dt [Allemagne] ; A. M. Jacobi [Allemagne]Bewertung einer Infusionbehandlung der rheumatoiden Arthritis durch Patienten und Rheumatologen
000D05 (2013) Rafael Mendonça Da Silva Chakr [Brésil] ; José Alexandre Mendonça [Brésil] ; Claiton Viegas Brenol [Brésil] ; Ricardo Machado Xavier [Brésil] ; João Carlos Tavares Brenol [Brésil]Assessing rheumatoid arthritis disease activity with ultrasound
000D26 (2013) A. Matucci [Italie] ; S. Pratesi [Italie] ; G. Petroni [Italie] ; F. Nencini [Italie] ; G. Virgili [Italie] ; M. Milla [Italie] ; E. Maggi [Italie] ; A. Vultaggio [Italie]Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab
000E83 (2012) Makio Kusaoi [Japon] ; Ken Yamaji ; Go Murayama ; Misa Yasui ; Risa Yamada ; Ruka Hishinuma ; Takuya Nemoto ; Katsura Hohtatsu ; Michiaki Kageyama ; Toshio Kawamoto ; Kaoru Sugimoto ; Fumio Sekiya ; Takayuki Kon ; Michihiro Ogasawara ; Kazuo Kempe ; Hiroshi Tsuda [Japon] ; Yoshinari TakasakiGene Expression Analysis Using a High‐Resolution DNA Microarray of Peripheral Whole Blood Immediately Before and After Leukocytapheresis for Rheumatoid Arthritis
000F24 (2007) Michael S. Zandi [Royaume-Uni] ; Alasdair J. Coles [Royaume-Uni]Notes on the kidney and its diseases for the neurologist
001230 (2013) Paweł Kawalec [Pologne] ; Alicja Mikrut [Pologne] ; Natalia Wi Niewska [Pologne] ; Andrzej Pilc [Pologne]The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
001231 (2011) Ilaria Marigo [Royaume-Uni] ; Francesco Dazzi [Royaume-Uni]The immunomodulatory properties of mesenchymal stem cells
001238 (2011) Markus Braun-Falco [Allemagne] ; Thomas Ruzicka [Allemagne]Skin manifestations in autoinflammatory syndromes

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "them" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "them" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    them
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021